|
0
|
|
Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
(linkinghub.elsevier.com)
|
Heath PT
…
Madhi SA
Lancet Infectious Diseases
2026-05-01
|
#infection
#vaccination
#pregnancy
#immunogenicity
#safety
|
|
0
|
|
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study.
(linkinghub.elsevier.com)
|
Razzini JL
…
Martinon-Torres F
Lancet Infectious Diseases
2026-05-01
|
#infection
#vaccination
#epidemiology
#prophylaxis
#rsv
|
|
0
|
|
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Leitner DR
…
Waldor MK
Lancet Infectious Diseases
2026-05-01
|
#vaccination
#immunogenicity
#safety
#attenuation
#cholera
|
|
0
|
|
Kyasanur Forest disease: an emerging arboviral threat.
(linkinghub.elsevier.com)
|
Pandey N
…
Singh SK
Lancet Infectious Diseases
2026-05-01
|
#vaccination
#transmission
#arbovirus
#zoonosis
#hemorrhagic fever
|
|
0
|
|
The promises and challenges of neoantigen cancer vaccines.
(nature.com)
|
Ott PA
Nature Biotechnology
2026-05-01
|
#vaccination
#cancer
#rna
#epitope
#immunogenicity
|
|
0
|
|
B cell imprinting in children impairs antibodies to the haemagglutinin stalk.
(nature.com)
|
Sun J
…
Wilson PC
Nature
2026-05-01
|
#vaccination
#influenza
#immunity
#antibody
#imprinting
|
|
0
|
|
Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study.
(linkinghub.elsevier.com)
|
Kone M
…
Sagara I
Lancet Infectious Diseases
2026-05-01
|
#vaccination
#malaria
#transmission
#immunogenicity
#adjuvant
|
|
0
|
|
A broadly protective antibody targeting gammaherpesvirus gB.
(nature.com)
|
Sun C
…
Zeng MS
Nature
2026-05-01
|
#virulence
#vaccination
#immunity
#neutralization
#structural
|
|
0
|
|
Prevalence and clinical outcomes of respiratory syncytial virus, COVID-19, and influenza among older hospitalized adults: the EVERY prospective cohort study.
(linkinghub.elsevier.com)
|
Morimoto T
…
Nakamura T
Clinical Microbiology and Infection
2026-05-01
|
#infection
#vaccination
#respiratory
#cohort
#mortality
|
|
0
|
|
Human Respiratory Syncytial Virus in Vaccinated and Unvaccinated Adults, Georgia, USA, 2024-2025.
(wwwnc.cdc.gov)
|
Rachida S
…
Piantadosi A
Emerging Infectious Diseases
2026-05-01
|
#vaccination
#evolution
#sequencing
#surveillance
|
|
0
|
|
Global vaccine development.
(nature.com)
|
Kim JH
…
Ndembi N
Nature Medicine
2026-05-01
|
#vaccination
#immunity
#immunogenicity
|